Risk factors for hepatitis C recurrence after liver transplantation.
about
Management of hepatitis c genotype 4 in the liver transplant settingChallenges of recurrent hepatitis C in the liver transplant patientImpact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients.Human liver transplantation as a model to study hepatitis C virus pathogenesisAntiviral treatment for hepatitis C virus infection after liver transplantation.Management of recurrent hepatitis C virus after liver transplantation.Liver transplantation in HCV/HIV positive patients.Major challenges limiting liver transplantation in the United States.Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients.Living-donor liver transplantation and hepatitis CMatching donor to recipient in liver transplantation: Relevance in clinical practice.Liver transplantation for liver disease caused by hepatitis C virus infection.Predictors of disease recurrence post living donor liver transplantation in end stage chronic HCV patients.Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.Hepatitis C virus treatment pre- and post-liver transplantation.Post-transplant liver biopsy and the immune response: lessons for the clinician.New insights in recurrent HCV infection after liver transplantationA retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients.Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances.Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort.Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C.Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States.REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C.Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipientsDonation after cardiac death organs for patients with hepatitis C virus: are we rolling the dice, or are they just as good as any?Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation.Virus-drug interactions--molecular insight into immunosuppression and HCV.A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation.The Role of Monocyte/Macrophage and CXCR3 in Differentiation between Recurrent Hepatitis C and Acute Cellular Rejection Postliver Transplantation.The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation.Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort StudyLiver transplantation and hepatitis C
P2860
Q26749326-7666BF54-E454-429F-8BAA-403982EB92AFQ27011871-0E09E273-696D-49CA-B1C8-091ED858FA3FQ34168552-E77863DF-644D-4633-86CA-D5A2A4E292D4Q34197528-889742C1-BF53-4EA8-A2DB-04088FC826C2Q34340293-334E415A-6102-4309-9230-BAB37A36C3D5Q34589655-82DBDF48-A864-45F3-BDE4-F479E724E678Q34640985-DCDCA883-8B77-46D9-9D5C-C9CCEED2A7A4Q35194675-D9D70A1A-3ABC-4992-B443-7A49FCD25BD2Q35210857-253F99BC-692E-445F-9945-ECF2773E25BAQ36011590-B11BB8F7-0961-4008-A10F-BC5180F9EC71Q36587253-081B75F2-A428-4EC4-854D-466C9691A97CQ37358273-0092A4F1-FD84-44EB-8A65-9D754B6CF685Q37396780-6938D5CF-6819-4E22-83C0-F43064EF44C7Q37628365-5F5D0672-F653-4B31-9C99-2DF57F66B582Q37777154-590F2ABE-49DE-40AE-BEC6-DCB4D3785494Q37798839-B3677A59-DECA-4182-9C6F-11941815B23AQ37972771-F723E4B0-75CC-4B91-A88C-9028B21E379EQ38053173-E0053F82-3F32-4E22-AC7F-F61A12ED5966Q38109628-AA2DB7DD-705C-43DB-B482-19745C28A635Q38286355-05C346FF-1A15-48EF-8F35-F2A407B2437FQ38584289-90E9FE1C-90C8-453C-9B41-5E684857E165Q40108499-B81048AE-3702-4412-ABB2-07C8CAE46EDBQ41706864-F807F527-D170-4A75-91F0-5F4CF355F946Q41924793-50857EC7-2699-4BCF-8342-F70CBEED6890Q42241628-D3FF6FAD-D7AD-42A7-BD82-3BE863933450Q42285158-5CE82BE6-9C17-407D-B9E5-427EF47DB9E8Q42847746-35BB643C-B419-43D3-8351-1156D1C5DCA8Q43036082-281FAE36-18B6-4F7E-A1A7-93578D37AAEFQ43037191-E61FEB4D-F9B5-4CDA-9995-275F8690F05BQ45358300-99D51C3F-EE29-4F7F-81BF-ED13C568745BQ45361290-3778E111-6E26-4321-8ADC-E5DC27F62284Q47878009-700D1228-3029-45FE-959F-CEBC8815D738Q55023267-F627A7EE-B8A1-4DF1-A287-377160B8EF74Q55692477-71994F7E-E149-4DF1-A419-D9B09F301260Q58204653-4940ED9B-9D40-4E92-AE15-C7BD0922B9D4Q58704499-C4796DC9-E396-496F-ACD8-C77614BCF60F
P2860
Risk factors for hepatitis C recurrence after liver transplantation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risk factors for hepatitis C recurrence after liver transplantation.
@en
type
label
Risk factors for hepatitis C recurrence after liver transplantation.
@en
prefLabel
Risk factors for hepatitis C recurrence after liver transplantation.
@en
P2860
P1476
Risk factors for hepatitis C recurrence after liver transplantation.
@en
P2093
P2860
P356
10.1111/J.1365-2893.2007.00920.X
P478
14 Suppl 1
P577
2007-11-01T00:00:00Z